Topic: AI in Life Sciences
Speakers:
Peter Beardsley, NovoTech Patent Firm
Kate Mead, Lee & Hayes
David Sheldon, Christensen O’Connor Johnson Kindness PLLC
Benjamin Keim, Newport IP
This panel discussion will explore the integration and impact of AI in the life sciences sector, including applications in drug screening, drug discovery, and medical devices. The panel will address key legal and practice challenges such as data ownership, model security, the distinction between AI tool usage and AI-generated contributions, open-source software (OSS) licensing, and patentability considerations (enablement, definiteness, and subject matter eligibility). Panelists will share practical insights, examine relevant court cases, and discuss best practices for navigating these emerging issues.
CLE: Up to 1.0 General Credit, pending approval
